Frontlight ResearchEarly access
Trial site
Oslo
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma4 trials
- Multiple sclerosis3 trials
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Sanofi7 trials
Running trials
Active, not recruiting
Active, not recruiting
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
Closed trials
Completed
Terminated
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026